Volume 29, Number 11—November 2023
Synopsis
Clinical Manifestations and Genomic Evaluation of Melioidosis Outbreak among Children after Sporting Event, Australia
Figure 5

Figure 5. Clinical images of adverse reactions secondary to trimethoprim/sulfamethoxazole among children treated for cutaneous melioidosis after a sporting event, Australia. A) Widespread, erythematous, pruritic rash in case-patient 1 that began 9 days after commencing trimethoprim-sulfamethoxazole. B) Lip swelling and a widespread erythematous rash in case-patient 2 that began 16 days after commencing trimethoprim/sulfamethoxazole.
Page created: September 14, 2023
Page updated: October 23, 2023
Page reviewed: October 23, 2023
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.